Identification and Characterisation of the Murine Homologue of the Gene Responsible for Cystinosis, Ctns
© Cherqui et al; licensee BioMed Central Ltd. 2000
Received: 15 November 2000
Accepted: 6 December 2000
Published: 6 December 2000
Cystinosis is an autosomal recessive disorder characterised by an intralysosomal accumulation of cystine, and affected individuals progress to end-stage renal failure before the age of ten. The causative gene, CTNS, was cloned in 1998 and the encoded protein, cystinosin, was predicted to be a lysosomal membrane protein.
We have cloned the murine homologue of CTNS, Ctns, and the encoded amino acid sequence is 92.6% similar to cystinosin. We localised Ctns to mouse chromosome 11 in a region syntenic to human chromosome 17 containing CTNS. Ctns is widely expressed in all tissues tested with the exception of skeletal muscle, in contrast to CTNS.
We have isolated, characterised and localised Ctns, the murine homologue of CTNS underlying cystinosis. Furthermore, our work has brought to light the existence of a differential pattern of expression between the human and murine homologues, providing critical information for the generation of a mouse model for cystinosis.
Cystinosis is an autosomal recessive disorder characterised by an intralysosomal accumulation of cystine. The underlying metabolic defect is a defective transport of cystine across the lysosomal membrane [1, 2]. Cystine is poorly soluble and forms crystals in the lysosomes as its concentration increases. Affected individuals develop a de Toni-Debré-Fanconi syndrome around six-eight months and suffer a progressive decline of glomerular filtration rate with end-stage renal failure occuring before the age of ten . Other clinical signs, such as severe growth retardation, ocular anomalies, diabetes, portal hypertension, hypothyroidism as well as muscular and neurological deterioration, appear due to the accumulation of cystine in different organs [2, 4]. Two other less severe forms (juvenile and ocular nonnephropathic) have also been described and shown to be allelic by complementation studies . To date, the most effective treatment of cystinosis is by the drug cysteamine which reduces intracellular levels of cystine [6, 7]. However, this treatment needs to be installed early on in the disease and at high doses, in order to be effective, and has a number of undesirable side effects.
The cystinosis gene was mapped to a 1 cM interval on the short arm of chromosome 17 between the markers D17S1798 and D17S1828 . The identification of a 57 kb  deletion, encompassing the marker D17S829 in 30% of affected individuals, allowed us to delineate the gene interval to within the boundaries of this deletion . Via a combinaton of large-scale sequencing and exon-trapping techniques, a novel gene was identified in the minimum deletion interval. The detection of various mutations within the coding region of this gene, named CTNS, validated it as responsible for all three forms of cystinosis [11, 12, 13]. CTNS is composed of 12 exons and the predicted translation start site is situated in exon 3. The 2.7 kb CTNS transcript contains a 1101 bp open reading frame (ORF) predicted to encode a protein of 367 amino acids, named cystinosin. Computer modelling using several hydrophobicity algorithms predicts that cystinosin is an integral membrane-spanning protein with seven transmembrane domains preceded by seven potential N-glycosylation sites and an uncleavable signal peptide at the amino-teminal end, and followed by a lysosomal targetting signal (GY-DQ-L) at the carboxy-terminal end . Taken together, these results suggest that cystinosin is a lysosomal membrane protein. However, as yet, the exact role of cystinosin in cystine transport is unknown and no animal model for cystinosis exists. Thus, as a first step towards the creation of such a model, we report here the isolation and characterisation of the murine homologue of CTNS.
Results and Discussion
In order to identify the murine homologue of CTNS, Ctns, a E11.5 mouse embryonic cDNA library (Clontech) was screened with a probe spanning the entire ORF of the human CTNS gene. Three overlapping cDNA clones were isolated and completely sequenced. The reconstructed sequence was homologous to a region of the human CTNS cDNA from base pair 565 to 2388. RACE (rapid amplification of cDNA ends) PCR of an E13.5 adaptor ligated-cDNA library (kindly provided by D. Weil, Institut Pasteur, Paris, France) was employed to isolate the remainder of the 5' and 3' murine cDNA sequences using the Ctns cDNA primers 1.1 (5'-ACC AAG AAC CGG ATC CTG GGG CA-3') and 2.1 (5'-GCC CTC TTT CCT ACC TCC ACT TTC TGA-3'), coupled with the adaptor primer AP1, and the nested primers 1.2 (5'-GCA TTT TTC TCT CCG CGA GGC AC-3') and 2.2 (5'-GTC AAT CAG TAA GCT GCC CTG GAT G-3'), coupled with AP2, for the amplification of the 5' and 3' ends, respectively (Marathon-Ready cDNA kit, Clontech).
In order to determine the exon/intron structure of Ctns, the 129/Sv Ev Tac flor DNA genomic library (Stratagene) was screened with a cDNA probe homologous to the CTNS exons 7 to 12 and four clones were isolated. Sequence analysis of their inserts demonstrated that the four overlapping clones spanned all the Ctns exons. The Ctns gene spans 14 kb is composed of ten exons and its exon/intron boundaries are identical to that of CTNS (Figure 1B). A combination of Long Range PCR (Expand Long Template PCR System, Boehringer Mannheim) and sequencing permitted an estimation of intron sizes. A comparison of the sizes of CTNS and Ctns introns showed that, with the exception of the human introns 3 and 5, intron sizes were similar between both species (Figure 1B).
The chromosomal localisation of the Ctns gene was determined by PCR amplification of the mouse T31 irradiation hybrid panel  with the primers LOC/1 (5'-TGT GGC CCA TGG ACT TGA AG-3') and LOC/2 (5'-CAA TCT GGC AGG CAC CTC A-3') situated in the 3' non-coding region. Two point lod score analysis resulted in a significant score of 5.37 and 5.36 with the chromosome 11 markers D11Mit279 and D11Mit7, respectively. A highly significant score of 12.25 and 11.09 was obtained with the ESTs AA589579 and R74628, respectively. R74628 maps distal to D11Mit7 and both of these markers are located within two contigs which lie in the region of synteny with human chromosome 17. Hence, this leads us to assume that Ctns also lies in the region of chromosome 11 syntenic with chromosome 17 which contains the human CTNS gene.
Although, the encoded products of CTNS, the gene underlying nephropathic cystinosis, and its murine homologue, Ctns, are highly conserved between man and mouse, they have a differential expression pattern. This information is crucial for the analysis of a mouse model for cystinosis which, in the absence of a spontaneous mouse mutant, we are currently generating in order to study the pathogenesis of cystinosis in vivo.
The chromosomal localisation of the murine Ctns gene was part of a service offered by the EEC Mouse Mapping Consortium led by Philip Avner (Institut Pasteur, Paris, France). V. Kalatzis was supported by the Institut Electricité Santé. The work presented here was supported by grants from Vaincre les Maladies Lysosomales, INSERM (programme APEX), Association Française contre les Myopathies and Association pour l'Utilisation du Rein Artificel.
- Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD: Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science. 1982, 217: 1263-1265.View ArticlePubMedGoogle Scholar
- Gahl WA, Schneider JA, Aula PP: Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In The metabolic and molecular basis of inherited disease. Edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill,. 1995, 3763-3797.Google Scholar
- Lemire J, Kaplan BS: The various manifestations of the nephropathic form of cystinosis. Am J Nephrol. 1984, 4: 81-85.View ArticlePubMedGoogle Scholar
- Schneider JA, Katz B, Melles RB: Update on nephropathic cystinosis. Pediatr Nephrol. 1990, 4: 645-653.View ArticlePubMedGoogle Scholar
- Pellett OL, Smith ML, Greene AA, Schneider JA: Lack of complementation in somatic cell hybrids between fibroblasts from patients with different forms of cystinosis. Proc Natl Acad Sci USA. 1988, 85: 3531-3534.PubMed CentralView ArticlePubMedGoogle Scholar
- Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesseman JJ, Corden BJ, Schneider JA: Cysteamine therapy for children with nephropatic cystinosis. N Engl J Med. 1987, 316: 971-977.View ArticlePubMedGoogle Scholar
- Markello TC, Bernardini IM, Gahl WA: Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med. 1993, 328: 1157-1162. 10.1056/NEJM199304223281604.View ArticlePubMedGoogle Scholar
- Jean G, Fuchshuber A, Town MM, Gribouval O, Schneider JA, Broyer M, van't Hoff W, Niaudet P, Antignac C: High-resolution mapping of the gene for cystinosis, using combined biochemical and linkage analysis. Am J Hum Genet. 1996, 58: 535-543.PubMed CentralPubMedGoogle Scholar
- Touchman JW, Anikster Y, Dietrich NL, Braden Maduro VV, McDowell G, Shotelersuk V, Bouffard GG, Beckstrom-Sternberg M, Gahl WA, Green ED: The Genomic Region Encompassing the Nephropathic Cystinosis Gene (CTNS): Complete Sequencing of a 200-kb Segment and Discovery of a Novel Gene within the Common Cystinosis-Causing Deletion. Genome Res. 2000, 10: 165-173. 10.1101/gr.10.2.165.PubMed CentralView ArticlePubMedGoogle Scholar
- Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C: A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet. 1998, 18: 319-324.View ArticlePubMedGoogle Scholar
- Theone J, Lemons R, Anikster Y, Mullet J, Paelicke K, Lucero C, Gahl W, Schneider J, Shu SG, Campbell HT: Mutations of CTNS Causing Intermediate Cystinosis. Mol Genet Metab. 1999, 67: 283-293. 10.1006/mgme.1999.2876.View ArticleGoogle Scholar
- Attard M, Jean G, Forestier L, Cherqui S, van't Hoff W, Broyer M, Antignac C, Town M: Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet. 1999, 8: 2507-2514. 10.1093/hmg/8.13.2507.View ArticlePubMedGoogle Scholar
- Anikster YA, Lucero C, Guo J, Huizing M, Shotelersuk V, Bernardini I, McDowell G, Iwata F, Kaiser-Kupfer MI, Jaffe R: Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations. Pediatr Res. 2000, 47: 17-23.View ArticlePubMedGoogle Scholar
- Rotwein P, Hall LJ: Evolution of insulin-like growth factor II: characterization of the mouse IGF-II gene and identification of two pseudo-exons. DNA Cell Biol. 1990, 9: 725-735.View ArticlePubMedGoogle Scholar
- Gessler M, Bruns GA: Sequence of the WT1 upstream region including the Wit-1 gene. Genomics. 1993, 17: 499-501. 10.1006/geno.1993.1355.View ArticlePubMedGoogle Scholar
- Stayner CK, Cunliffe HE, Ward TA, Eccles MR: Cloning and characterization of the human PAX2 promoter. J Biol Chem. 1998, 273: 25472-25479. 10.1074/jbc.273.39.25472.View ArticlePubMedGoogle Scholar
- McCarthy LC, Terrett J, Davis ME, Knights CJ, Smith AL, Critcher R, Schmitt K, Hudson J, Spurr NK, Goodfellow PN: A first generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res. 1997, 7: 1153-1161.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.